Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia
by on Tuesday, August 7th, 2012 | No Comments
Condition: Breast Cancer
Intervention: Drug: GCSF administration on days 8 and 12 after chemotherapy
Sponsors: Jules Bordet Institute; Jules Bordet Institute
Recruiting – verified July 2012
Follow this link: Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia